Free Trial
NASDAQ:ZVSA

ZyVersa Therapeutics (ZVSA) Stock Price, News & Analysis

ZyVersa Therapeutics logo
$0.18 -0.01 (-5.41%)
As of 05/13/2026 02:22 PM Eastern

About ZyVersa Therapeutics Stock (NASDAQ:ZVSA)

Advanced

Key Stats

Today's Range
$0.18
$0.23
50-Day Range
$0.18
$0.27
52-Week Range
$0.11
$1.67
Volume
41,063 shs
Average Volume
53,004 shs
Market Capitalization
$1.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ZVSA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ZyVersa Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ZVSA Stock News Headlines

Read this or regret it forever
Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change.tc pixel
ZyVersa Therapeutics Delays 10-Q Filing
ZyVersa Therapeutics Faces Nasdaq Delisting Notice
See More Headlines

ZVSA Stock Analysis - Frequently Asked Questions

ZyVersa Therapeutics' stock was trading at $0.1336 at the beginning of the year. Since then, ZVSA shares have increased by 34.7% and is now trading at $0.18.

ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA) issued its earnings results on Monday, May, 12th. The company reported ($0.73) earnings per share for the quarter, missing the consensus estimate of ($0.40) by $0.33.

ZyVersa Therapeutics shares reverse split on Friday, April 26th 2024.The 1-10 reverse split was announced on Friday, April 26th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, April 26th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of ZVSA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ZyVersa Therapeutics investors own include Tesla (TSLA), Lucid Group (LCID), NVIDIA (NVDA), XPENG (XPEV), Akebia Therapeutics (AKBA), JPMorgan Chase & Co. (JPM) and Eli Lilly and Company (LLY).

Company Calendar

Last Earnings
5/12/2025
Today
5/14/2026
Next Earnings (Estimated)
5/15/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ZVSA
CIK
1859007
Fax
N/A
Employees
2
Year Founded
2014

Profitability

EPS (Trailing Twelve Months)
($1.34)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$9.41 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-109.54%
Return on Assets
-43.95%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.18
Quick Ratio
0.18

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.40 per share
Price / Book
0.05

Miscellaneous

Outstanding Shares
7,936,000
Free Float
4,863,000
Market Cap
$1.43 million
Optionable
Not Optionable
Beta
0.80

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:ZVSA) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners